We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MVIS:NASDAQMicroVision, Inc. analysis

Data as of Sep 7, 2026 - not real-time

Latest price
$1.65
Risk: high
9/10High risk

Summary

At $1.65, MicroVision, Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. Across the trailing 30 sessions it lost 56.0%. RSI sits at 31.2, which reads as approaching oversold, and MACD momentum is bullish. Price has been bracketed by support at $1.58 and resistance at $4.90.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Revenue is growing at 850.3%.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 197.7%, a beta of 2.72 and a maximum drawdown of 92.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: sell, at a conviction of 4 out of 10.

Top market events

  • Advancing Lidar 2.0 strategy with expanding customer engagements, new product launches, strengthened leadership team,...
  • Yahoo Finance1monMicrovision, Inc. MVIS Q2 FY2026 earnings call transcriptMicroVision delivered Q2 2026 revenue of...
  • REDMOND, WA / ACCESS Newswire / September 4, 2026 / MicroVision, Inc.

Market outlook

Short term

< 1 year

Cautious

Model confidence4/104 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 8.95
  • MACD momentum is positive

Medium term

1–3 years

Cautious

Model confidence4/104 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 8.95
  • 30-day volatility of 197.7%

Long term

> 3 years

Cautious

Model confidence4/104 out of 10

Key factors

  • Negative return on equity of -233.7%
  • Revenue growth of +850.3%
  • Negative free cash flow

Key metrics

Financial health

Revenue Growth850.30%
P/E Ratio-8.7
ROE-233.74%
ROA-45.02%
Debt/Equity220.43
P/B Ratio1.9
Op. Cash Flow$-67481000
Free Cash Flow$-22361500
Industry P/E33.2

Technical analysis

TrendBearish
RSI31.2
Support$1.58
Resistance$4.90
MA 20$2.24
MA 50$3.63
MA 200$8.95
MACDBullish
VolumeDecreasing
Fear & Greed Index94.11

Valuation

GradeFair
TypeGrowth

Risk assessment

Beta2.72
Volatility197.70%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.